Carvedilol - Latest Advances

Potentiation of ryanodine receptor-mediated calcium release by MAPK is responsible for epidermal transformation and carcinogenesis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 10, 2025

Mitigating Doxorubicin-Induced Toxicity in Breast Cancer Treatment with In Situ pH-Sensitive Carvedilol-loaded Transbilosomes: In Vitro and In Vivo Characterization.

Journal: Journal of drug targeting

Published: December 08, 2025

Availability and Affordability of Essential Antihypertensive Medicines in Public and Private Primary Care Drug Facilities in a 4th Class Municipality in the Philippines.

Journal: Acta medica Philippina

Published: December 03, 2025

Acute cardiovascular complaints after recreational drug use

Journal: Nederlands tijdschrift voor geneeskunde

Published: November 19, 2025

Carvedilol microemulsion-loaded oleogel for oral delivery: investigation of in vitro drug release and evaluation of chemical and physical stability.

Journal: Pharmaceutical development and technology

Published: November 04, 2025

In vitro and in vivo evaluation of the therapeutic efficacy of in-situ pH-sensitive carvedilol-loaded novasomes as a therapy for diabetes-associated coronary artery disease.

Journal: Journal of drug targeting

Published: October 30, 2025

Retraction notice to "Two types of core/shell fibers based on carboxymethyl chitosan and sodium carboxymethyl cellulose with self-assembled liposome for buccal delivery of carvedilol across TR146 cell culture and porcine buccal mucosa" [International Journal of Biological Macromolecules 128 (2019) 700-709].

Journal: International journal of biological macromolecules

Published: October 29, 2025

In vitro and in vivo assessment of the bioavailability and efficacy of carvedilol-loaded novasomes as a therapy for diabetes mellitus-associated ischemic stroke.

Journal: Journal of drug targeting

Published: October 23, 2025

Current Status and Future Directions in the Pharmacologic Management of Cirrhosis.

Journal: Clinics in liver disease

Published: October 18, 2025

Cardioprotective effect of apigenin and carvedilol against isoproterenol-induced myocardial infarction in rats.

Journal: Drug and chemical toxicology

Published: October 16, 2025

Carvedilol microemulsion-loaded oleogel: development and validation via an HPLC method, identification of three degradation products, and toxicity prediction.

Journal: Analytical methods : advancing methods and applications

Published: October 15, 2025

Beta-Blockers as Potential Adjuvants in Melanoma Treatment.

Journal: Toxics

Published: October 12, 2025

Filters

Potentiation of ryanodine receptor-mediated calcium release by MAPK is responsible for epidermal transformation and carcinogenesis.

Potentiation of ryanodine receptor-mediated calcium release by MAPK is responsible for epidermal transformation and carcinogenesis.

Mitigating Doxorubicin-Induced Toxicity in Breast Cancer Treatment with In Situ pH-Sensitive Carvedilol-loaded Transbilosomes: In Vitro and In Vivo Characterization.

Mitigating Doxorubicin-Induced Toxicity in Breast Cancer Treatment with In Situ pH-Sensitive Carvedilol-loaded Transbilosomes: In Vitro and In Vivo Characterization.

Availability and Affordability of Essential Antihypertensive Medicines in Public and Private Primary Care Drug Facilities in a 4th Class Municipality in the Philippines.

Availability and Affordability of Essential Antihypertensive Medicines in Public and Private Primary Care Drug Facilities in a 4th Class Municipality in the Philippines.

Acute cardiovascular complaints after recreational drug use

Acute cardiovascular complaints after recreational drug use

Carvedilol microemulsion-loaded oleogel for oral delivery: investigation of in vitro drug release and evaluation of chemical and physical stability.

Carvedilol microemulsion-loaded oleogel for oral delivery: investigation of in vitro drug release and evaluation of chemical and physical stability.

In vitro and in vivo evaluation of the therapeutic efficacy of in-situ pH-sensitive carvedilol-loaded novasomes as a therapy for diabetes-associated coronary artery disease.

In vitro and in vivo evaluation of the therapeutic efficacy of in-situ pH-sensitive carvedilol-loaded novasomes as a therapy for diabetes-associated coronary artery disease.

In vitro and in vivo assessment of the bioavailability and efficacy of carvedilol-loaded novasomes as a therapy for diabetes mellitus-associated ischemic stroke.

In vitro and in vivo assessment of the bioavailability and efficacy of carvedilol-loaded novasomes as a therapy for diabetes mellitus-associated ischemic stroke.

Current Status and Future Directions in the Pharmacologic Management of Cirrhosis.

Current Status and Future Directions in the Pharmacologic Management of Cirrhosis.

Cardioprotective effect of apigenin and carvedilol against isoproterenol-induced myocardial infarction in rats.

Cardioprotective effect of apigenin and carvedilol against isoproterenol-induced myocardial infarction in rats.

Carvedilol microemulsion-loaded oleogel: development and validation via an HPLC method, identification of three degradation products, and toxicity prediction.

Carvedilol microemulsion-loaded oleogel: development and validation via an HPLC method, identification of three degradation products, and toxicity prediction.

Beta-Blockers as Potential Adjuvants in Melanoma Treatment.

Beta-Blockers as Potential Adjuvants in Melanoma Treatment.